Twist Bioscience expands gene product line with launch of Clonal-Ready Gene Fragments


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Twist Bioscience expands gene product line with launch of Clonal-Ready Gene Fragments
It can be used to build constructs and minimize the time and cost of screening for perfect clones

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Clonal-Ready Gene Fragments, providing customers with a complete offering for genes. Twist’s best-in-class Gene Fragments, with and without adapters, can be used to build constructs and minimize the time and cost of screening for perfect clones.

“Our industry-leading production process delivers high-quality Gene Fragments quickly, reliably, and affordably so that our customers can order the DNA that they want exactly how they want it,” said Emily M. Leproust, PhD, CEO and co-founder of Twist Bioscience. “Importantly, we are now able to better address a segment of the synthetic biology market who make their own Clonal Genes rather than purchasing them, reaching the large number of customers that need smaller amounts of DNA to facilitate their experiments seamlessly.”

Gene Fragments begin as oligonucleotides synthesized on Twist Bioscience’s proven semiconductor-based silicon platform. The oligonucleotides are then annealed together and PCR-amplified to produce a double-stranded DNA fragment and error-corrected through an enzymatic reaction. The resulting product is a ready-to-use Gene Fragment that is compatible with many applications including cloning, gene and protein expression, pathway and enzyme engineering and enzyme optimization.

Based on a comparative study conducted by Twist, Twist Gene Fragments demonstrated the lowest error rate, with a nearly 2-fold improvement across all Gene Fragment size ranges at 1:5,300. For shorter oligonucleotides 300 to 800 base pairs in length, the error rate was 1:6,200. Low error rates translate into the selection of fewer colonies, saving time and budget.

Tags : #TwistBioscience #LatestNewsonTwistBioscience11thDec #LatestPharmaNews11thDec #Clonal-ReadyGeneFragments

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026